BDBM235029 4-(1-(2-ethyl-6-(trifluoromethyl)benzyl)-4-fluoro-1H-indazol-3-yl)-5-fluoro-2-hydroxybenzoic acid (9A)::US9556168, 9A

SMILES CCc1cccc(c1Cn1nc(-c2cc(O)c(cc2F)C(O)=O)c2c(F)cccc12)C(F)(F)F

InChI Key InChIKey=UQDTXJLULBMLPM-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 235029   

TargetNuclear receptor ROR-gamma(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM235029(4-(1-(2-ethyl-6-(trifluoromethyl)benzyl)-4-fluoro-...)
Affinity DataIC50:  175nMpH: 7.0Assay Description:The compounds of the invention inhibit RORgammaT activity. Activation of RORgammaT activity can be measured using, e.g., biochemical TR-FRET assay. I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent